Recent events
Recent events tied to this brand in public sources.
Back to profile4 entries
2021
Smile CDR closes $20 million Series A funding
Smile CDR announced that it had closed $20 million in Series A growth capital led by 30 North Group and UPMC Enterprises.
2021
Sempre Health closes $15 million Series B financing
Sempre Health announced the closing of a $15 million Series B financing to advance its network of payors and pharmaceutical manufacturers nationwide and expand the number of patients it can serve.
2020
SparingVision announces €44.5 million financing
SparingVision announced a €44.5 million financing round led by 4BIO Capital and UPMC Enterprises, with Ysios Capital and existing investors also participating.
2019
Werewolf Therapeutics completes $56 million Series A financing
Werewolf Therapeutics announced completion of a $56 million Series A financing led by MPM Capital and Longwood Fund, with four other investors joining the round.